The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The XEC variant of Covid is quickly becoming the dominant strain of the winter, but the current vaccines may not be as ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Shares in Ferrari were trending in pre-market trading as the carmaker unveiled its new limited edition supercar that has ...

RLF, NATIONAL TRIAL COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities ...

Apple is the most admired company in the world for the 17th consecutive year, according to Fortune. Once again the tech giant finished first in the magazine’s annual ranking of corporate reputation, ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...